Cited 4 times since 2020 (0.9 per year) source: EuropePMC Journal of the American College of Cardiology, Volume 75, Issue 4, 1 1 2020, Pages 448-451 Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES. Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Schwartz GG, ODYSSEY OUTCOMES Investigators†